Aclaris Therapeutics, Inc. (ACRS)
3.75
-0.08
(-2.09%)
USD |
NASDAQ |
Oct 23, 16:00
3.755
0.00 (0.00%)
After-Hours: 20:00
Aclaris Therapeutics Price : 3.75 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 3.81 | 3.845 | 3.681 | 3.75 | 2.290M |
| Oct 22, 2026 | 3.77 | 3.98 | 3.735 | 3.83 | 2.799M |
| Oct 21, 2026 | 3.74 | 3.97 | 3.69 | 3.81 | 2.663M |
| Oct 20, 2026 | 3.41 | 3.81 | 3.37 | 3.77 | 3.499M |
| Oct 19, 2026 | 3.28 | 3.50 | 3.255 | 3.48 | 1.747M |
| Oct 16, 2026 | 3.51 | 3.53 | 3.245 | 3.28 | 2.457M |
| Oct 15, 2026 | 3.42 | 3.505 | 3.34 | 3.49 | 2.587M |
| Oct 14, 2026 | 3.38 | 3.47 | 3.34 | 3.38 | 2.589M |
| Oct 13, 2026 | 3.65 | 3.652 | 3.41 | 3.47 | 3.439M |
| Oct 12, 2026 | 3.80 | 3.835 | 3.585 | 3.60 | 3.429M |
| Oct 09, 2026 | 3.76 | 3.94 | 3.64 | 3.83 | 5.060M |
| Oct 08, 2026 | 3.37 | 3.815 | 3.182 | 3.79 | 8.735M |
| Oct 07, 2026 | 3.595 | 3.62 | 3.315 | 3.40 | 9.003M |
| Oct 06, 2026 | 4.22 | 4.24 | 3.65 | 3.70 | 3.531M |
| Oct 05, 2026 | 4.34 | 4.41 | 4.065 | 4.27 | 7.015M |
| Oct 02, 2026 | 4.44 | 4.52 | 4.205 | 4.39 | 6.209M |
| Oct 01, 2026 | 5.18 | 5.18 | 4.35 | 4.41 | 5.177M |
| Sep 30, 2026 | 5.30 | 5.395 | 5.21 | 5.26 | 2.263M |
| Sep 29, 2026 | 5.42 | 5.45 | 5.155 | 5.28 | 2.052M |
| Sep 28, 2026 | 5.07 | 5.465 | 5.02 | 5.43 | 2.429M |
| Sep 25, 2026 | 5.39 | 5.538 | 5.095 | 5.15 | 1.474M |
| Sep 24, 2026 | 5.24 | 5.44 | 5.145 | 5.38 | 2.489M |
| Sep 23, 2026 | 5.70 | 5.74 | 5.035 | 5.26 | 1.963M |
| Sep 22, 2026 | 5.63 | 5.765 | 5.50 | 5.72 | 2.879M |
| Sep 21, 2026 | 5.55 | 5.62 | 5.40 | 5.57 | 1.521M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Corcept Therapeutics, Inc. | 85.86 |
| Alumis, Inc. | 6.78 |
| ANI Pharmaceuticals, Inc. | 72.61 |
| Veru, Inc. | 2.24 |
| Johnson & Johnson | 263.81 |
Price Related Metrics
| PS Ratio | 58.95 |
| Price to Book Value | 4.209 |
| Earnings Yield | -15.61% |
| Market Cap | 524.34M |